Grace Lu-Yao, PhD, MPH
Grace Lu-Yao, PhD, MPH
Research & Practice Interests
Cancer Surveillance, Screening, and Treatment for Prostate Cancer
Outcomes Research and Cancer Epidemiology
Host Factors and Immunotherapy Outcomes
PhD, Yale University
MPH, Yale University
BS, State University of New York at Stony Brooke
Taipei Medical College
- Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy
- Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer
- Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities
- Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer
- Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
Research Professor, Jefferson College of Population Health
Professor, Sidney Kimmel Medical College
Vice Chair, Population Science, Medical Oncology, Thomas Jefferson University
Associate Director, Population Science, Sidney Kimmel Cancer Center
Research Director, Neu Center for Supportive Medicine and Cancer Survivorship, Sidney Kimmel Cancer Center
Dr. Grace Lu-Yao is a tenured Professor and Vice-Chair in the Department of Medical Oncology at Thomas Jefferson University. She also serves as the Associate Director of Population Science at the Sidney Kimmel Cancer Center (SKCC), an NCI-designated cancer center at Thomas Jefferson University.
Her research interests include cancer epidemiology, translational outcomes research, and geriatric oncology. Dr. Lu-Yao majored in biochemistry in undergraduate, earned her Ph.D. in epidemiology and Master of Public Health degrees from Yale University. She worked with the world-renowned outcome research pioneer, Dr. John E. Wennberg, at the Dartmouth Medical School in her early career and was elected to be a fellow of the American College of Epidemiology in 2006.
Dr. Lu-Yao, the PI of several NIH funded projects, is passionate about bringing tailored whole-person care to patients with cancer. Many of her research findings on cancer surveillance, screening, and treatment for prostate cancer have provided benchmark references and published in high-impact medical journals such as JAMA, Lancet, British Medical Journal, and European Urology. Many physicians have used her research findings to counseling patients. Dr. Lu-Yao has substantial experience in leading transdisciplinary teams and in integrating population science with basic and clinical science. In 2018, Dr. Lu-Yao received the Investigator's Award from the International Society of Geriatric Oncology.